This finding suggests the potential role of the molecule as a marker of the cardiovascular risk, which is even more crucial among patients with psoriasis, as the disease is linked to the greater carotid intima-media thickness and overproduction of pro-inflammatory adipokines by the epicardial adipose tissue, which in turn also influences PTX3 levels [23,24,25]. The gene discussed is PTX3; the disease is psoriasis.